Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy

被引:0
|
作者
Taylor, Edward [1 ,2 ]
Lukovic, Jelena [1 ,2 ]
Velec, Michael [1 ,2 ]
Shessel, Andrea [1 ]
Stanescu, Teodor [1 ,2 ]
Dawson, Laura [1 ,2 ]
Letourneau, Daniel [1 ,2 ]
Lindsay, Patricia [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
关键词
Image guided radiotherapy; magnetic resonance imaging; liver cancer; stereotactic body radiotherapy; RADIATION-THERAPY SMART; MALIGNANCIES; ABDOMEN; PELVIS; THORAX; IMPACT;
D O I
10.1080/0284186X.2020.1840625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Liver cancers are challenging to treat using image-guided radiotherapy (IGRT) due to motion and deformation of target volumes and organs at risk (OARs), as well as difficulties in visualising liver tumours using cone-beam computed tomography (CBCT) based IGRT. Liver cancer patients may thus benefit from magnetic resonance (MR)-guided daily adaptive re-planning. We evaluated the dosimetric impact of a daily plan adaptation strategy based on daily MR imaging versus CBCT-based IGRT. Methods Ten patients were studied who were treated with CBCT-guided five-fraction stereotactic body radiotherapy (SBRT) and underwent MR imaging before each fraction. Simulated reference plans were created on computer tomography (CT) images and adapted plans were created on the daily MR images. Two plan adaptation strategies were retrospectively simulated: (1) translational couch shifts to match liver, mimicking standard CBCT guidance and (2) daily plan adaptation based on reference plan clinical goals and daily target and OAR contours. Dose statistics were calculated for both strategies and compared. Results Couch shifts resulted in an average reduction in GTV D99% relative to reference plan values of 5.2 Gy (-12.5% of reference values). Daily plan adaptation reduced this to 0.8 Gy (-2.0%). For six patients who were OAR dose-limited on reference plans, couch shifts resulted in OAR dose violations in 28 out of 28 simulated fractions, respectively; no violations occurred using daily plan adaptation. No OAR dose violations occurred using either strategy for the four cases not OAR dose-limited at reference planning. Conclusions MR-guided daily plan adaptation ensured OAR dose constraints were met at all simulated treatment fractions while CBCT-based IGRT resulted in a systematic over-dosing of OARs in patients whose doses were limited by OAR dose at the time of reference planning.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 50 条
  • [1] Feasibility of magnetic resonance-guided stereotactic ablative body radiotherapy of liver cancer
    Picton, M.
    Batumalai, V.
    Crawford, D.
    Pagulayan, C.
    Hogan, L.
    Jelen, U.
    Loo, C.
    Dunkerley, N.
    Geddes, L.
    Sampaio, S.
    Heinke, M.
    Twentyman, T.
    Jameson, M.
    de Leon, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S298 - S299
  • [2] Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Reirradiation in the Abdomen
    Howard, T.
    Ferguson, D.
    Han, Z.
    Leeman, J. E.
    van Dams, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E238 - E238
  • [3] Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
    Weykamp, Fabian
    Katsigiannopulos, Efthimios
    Piskorski, Lars
    Regnery, Sebastian
    Hoegen, Philipp
    Ristau, Jonas
    Renkamp, C. Katharina
    Liermann, Jakob
    Forster, Tobias
    Lang, Kristin
    Koenig, Laila
    Rippke, Carolin
    Buchele, Carolin
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2022, 14 (24)
  • [4] Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer
    Darren M. C. Poon
    Bin Yang
    Hui Geng
    Oi Lei Wong
    Sin Ting Chiu
    Kin Yin Cheung
    Siu Ki Yu
    George Chiu
    Jing Yuan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 841 - 850
  • [5] Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer
    Poon, Darren M. C.
    Yang, Bin
    Geng, Hui
    Wong, Oi Lei
    Chiu, Sin Ting
    Cheung, Kin Yin
    Yu, Siu Ki
    Chiu, George
    Yuan, Jing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 841 - 850
  • [6] 1.5-Tesla Magnetic Resonance-Guided Adaptive Stereotactic Body Radiotherapy for Liver Malignancies
    Onal, C.
    Yavas, G.
    Yavas, C.
    Arslan, G.
    Efe, E.
    Haberal, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1117 - S1117
  • [7] Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma
    Mehanna, E.
    Van Dams, R.
    Mamon, H. J.
    Mancias, J. D.
    Lam, M.
    Tanguturi, S.
    Huynh, M. A.
    Venkatachalam, V.
    Fitzgerald, K. J.
    Mak, R. H.
    Martin, N. E.
    Han, Z.
    Chang, S. L.
    McGregor, B.
    Choueiri, T. K.
    Leeman, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E560 - E561
  • [8] An Essential Treatment Pattern of Lung Cancer: Magnetic Resonance-Guided Stereotactic Body Radiotherapy
    Wang, X.
    Li, Z.
    Yin, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E567 - E567
  • [9] Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort
    Leeman, Jonathan E.
    Cagney, Daniel N.
    Mak, Raymond H.
    Huynh, Mai Anh
    Tanguturi, Shyam K.
    Singer, Lisa
    Catalano, Paul
    Martin, Neil E.
    D'Amico, Anthony, V
    Mouw, Kent W.
    Nguyen, Paul L.
    King, Martin T.
    Han, Zhaohui
    Williams, Christopher
    Huynh, Elizabeth
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (05)
  • [10] Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
    Weykamp, Fabian
    Hoegen, Philipp
    Klueter, Sebastian
    Spindeldreier, C. Katharina
    Koenig, Laila
    Seidensaal, Katharina
    Regnery, Sebastian
    Liermann, Jakob
    Rippke, Carolin
    Koerber, Stefan A.
    Buchele, Carolin
    Debus, Juergen
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2021, 11